Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.40 |
| ▸ | FABP7 | O15540 | 2/20 | 0.40 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
| ▸ | TLR2 | O60603 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29447213 | 0.82 | KMT2A (0.66) | KMT2AHTR2ACA1CA2EPHX2 | |
| SCHEMBL730784 | 0.82 | KMT2A (0.66) | KMT2AHTR2ACA1CA2EPHX2 | |
| Bromide SCHEMBL2216954 | 0.81 | KMT2A (0.64) | KMT2ACA1CA2EPHX2FABP5 | |
| Hydrochloric Acid SCHEMBL966018 | 0.81 | KMT2A (0.64) | KMT2ACA1CA2EPHX2FABP5 | |
| Hydrochloric Acid SCHEMBL29599906 | 0.81 | KMT2A (0.64) | KMT2ACA1CA2EPHX2FABP5 | |
| SCHEMBL10149864 | 0.81 | KMT2A (0.48) | KMT2AHTR2ACA1CA2EPHX2 | |
| SCHEMBL15521241 | 0.80 | KMT2A (0.51) | KMT2ACA1CA2EPHX2FABP5 | |
| SCHEMBL13419384 | 0.80 | KMT2A (0.50) | KMT2ACA1CA2EPHX2FABP5 | |
| SCHEMBL21526565 | 0.78 | KMT2A (0.60) | KMT2ACA1CA2EPHX2FABP5 | |
| Phosphoric Acid SCHEMBL22468200 | 0.78 | KMT2A (0.60) | KMT2ACA1CA2EPHX2FABP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015164289-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS | CIDARA THERAPEUTICS, INC. (US) | 2015-10-29 | — | — | WO | disclosed |